Summary of the Conference Call for TuoSiDa Company Overview - **Company**: TuoSiDa - **Date of Call**: August 22, 2025 Key Points Industry and Company Performance - **Overall Revenue**: TuoSiDa reported a revenue growth of 22.66% in the first half of the year, with a gross margin of 38.83% [2][3] - **Industrial Robotics Segment**: Revenue slightly increased, with a notable 80% growth in multi-joint robots, while automation systems contracted due to a focus on major clients [2][4] - **Injection Molding Segment**: Auxiliary machine revenue grew by 30%, while main injection machine revenue declined by 30%. Electric injection machines generated several tens of millions in revenue, with improved gross margins [2][5] - **CNC Machine Tool Segment**: Revenue increased by 83.74% year-on-year, with approximately 200 units sold, driven by orders from humanoid robot parts processing and aerospace sectors [2][5] - **Green Energy and Environmental Management Systems**: Revenue significantly decreased, with a 60% drop, as the company is gradually divesting from this segment [5] Financial Metrics - **Net Profit**: The net profit attributable to shareholders was 28 million, a decrease of about 20% year-on-year [3] - **Gross Margins**: Expected gross margins for 2025 are approximately 40% for industrial robots and automation, 27%-28% for CNC machines, and around 9% for green energy [11] Market Dynamics - **Competition in CNC Machine Tools**: The industry is highly competitive, with some companies offering zero down payment and leasing options. TuoSiDa has not adopted such strategies, leading to a decline in prices and gross margins [9] - **International Market Growth**: Significant growth in overseas markets, with revenue excluding green energy products increasing by over 90% [12] Future Outlook - **Sales Projections for Electric Injection Machines**: Expected sales for the first half of 2025 are several tens of millions, with full-year projections reaching several hundreds of millions [7] - **Automation Business Orders**: Orders are primarily driven by clients establishing overseas factories, particularly for new Apple product processes, with a positive market response anticipated for 2026 [8] Strategic Partnerships - **Collaboration with AI Companies**: No new developments with Huawei on core algorithms; however, a partnership with Zhipu AI has been established to develop humanoid robots using their AI models [10] Operational Insights - **Cash Flow**: Operating cash flow increased significantly due to reduced taxes and employee compensation [20] - **Inventory Management**: High inventory turnover days (320 days) may lead to potential impairment provisions in the second half of the year [21] R&D and Product Development - **New Product Launches**: A global open day event is scheduled for September 12, 2025, to showcase AI-integrated products, including humanoid robots [22][23] Challenges and Risks - **Green Energy Business**: The company is in the process of divesting from the green energy segment, which has been a significant drag on overall performance [5][18] - **Market Uncertainties**: The company is navigating strategic adjustments and external uncertainties, particularly related to the green energy business and accounts receivable pressures [17][18] Conclusion TuoSiDa is experiencing growth in several segments, particularly in industrial robotics and CNC machine tools, while facing challenges in the green energy sector. The company is strategically focusing on international markets and partnerships to enhance its product offerings and operational efficiency.

Core Viewpoint - The company reported a revenue of 9.018 billion yuan for H1 2025, representing a year-on-year increase of 12.5%, and a net profit attributable to shareholders of 1.712 billion yuan, up 12.6% year-on-year [1] Industry Overview - The injection molding machine industry is experiencing growth driven by both industry prosperity and supply-demand dynamics, with a significant increase in exports due to domestic manufacturers accelerating overseas expansion [1] - The demand for injection molding machines is supported by their wide application in various sectors such as new energy vehicles, medical, and 3C electronics, leading to stable growth in demand [1] - In H1 2025, the export value of domestic injection molding machines increased by 29% year-on-year, with Southeast Asia showing a remarkable growth rate of 94%, accounting for 36% of total exports [1] - The global per capita plastic consumption is on the rise, with emerging markets having substantial room for growth due to lower consumption bases [1] Company Performance - The company achieved a gross margin of 32.8% in H1 2025, an increase of 0.5 percentage points year-on-year, and a net profit margin of 18.26%, remaining stable year-on-year [2] - Sales of complete injection molding machines increased by 12.1% year-on-year to 8.637 billion yuan, while parts and service sales grew by 21.0% to 381 million yuan [2] - The Mars and Jupiterr series of machines experienced rapid growth, driven by demand from overseas consumer goods and domestic new energy vehicles and home appliances [2] Competitive Positioning - As a leading player in the domestic injection molding machine industry, the company demonstrates significant competitive advantages, with core financial metrics outperforming peers [3] - The company’s high-performance electric injection molding machines, particularly the Changfei Ya series, are gaining traction globally, with over 30,000 units in use across approximately 60 countries [3] - The company is advancing its global strategy, establishing production capacities in India and Mexico, with new facilities in Japan and Serbia expected to commence operations in 2025 [3] - The company is enhancing its supply chain and implementing digital monitoring to reduce costs and improve efficiency, aligning with global demand [3]

Core Viewpoint - Guangdong Tosstar Technology Co., Ltd. is undergoing a strategic transformation focusing on product optimization and project reduction, resulting in a slight decline in overall revenue and a significant drop in net profit for the first half of 2025 [1] Group 1: Financial Performance - In the first half of 2025, the company achieved operating revenue of 2,873.22 million yuan, a year-on-year decrease of 0.13% [1] - The net profit attributable to shareholders decreased by 19.75% year-on-year, amounting to 28.73 million yuan [1] - The net profit excluding non-recurring gains and losses was 20.43 million yuan, down 28.53% year-on-year [1] Group 2: Business Segment Performance - In Q2 2025, product-related business saw a significant revenue increase of 31.62% year-on-year and 86.14% quarter-on-quarter [2] - The industrial robot segment generated revenue of 146.00 million yuan in the first half of 2025, reflecting a year-on-year growth of 22.55% [2] - The CNC machine tool business reported revenue of 163.67 million yuan, up 83.74% year-on-year, despite a decrease in gross margin by 3.67 percentage points [3] Group 3: Strategic Developments - The company has made advancements in embodied intelligence, with the new X5 motion controller achieving commercialization and integration with various AI platforms [4] - The company is expanding its overseas market presence, securing orders through participation in international exhibitions and targeting the South American market [4]

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Views - The company reported a revenue of 9.018 billion yuan for H1 2025, representing a year-on-year increase of 12.5%, and a net profit attributable to shareholders of 1.712 billion yuan, also up by 12.6% [2][6]. - The company's overseas market revenue grew by 34.65% year-on-year, with overseas revenue accounting for 42.3% of total revenue, up from 37.3% in 2024, indicating continuous global market share expansion [2][9]. - The company is accelerating its globalization strategy, implementing a "50-50 strategy" with new production capacities established in India and Mexico, and additional capacities planned in Japan and Serbia expected to commence production in 2025 [2][9]. Summary by Sections Company Performance - In H1 2025, the company achieved a revenue of 9.018 billion yuan, a 12.5% increase year-on-year, and a net profit of 1.712 billion yuan, reflecting a 12.6% growth [2][6]. - The gross margin for H1 2025 was 32.8%, up by 0.5 percentage points year-on-year, while the net profit margin remained stable at 18.26% [9]. Market Dynamics - The injection molding machine industry is experiencing a surge in demand due to the expansion of downstream manufacturers overseas and the release of potential in emerging markets [9]. - The export value of domestic injection molding machines increased by 29% year-on-year in H1 2025, with Southeast Asia showing a remarkable growth rate of 94% [9]. Competitive Position - The company is a leading player in the domestic injection molding machine industry, with significant competitive advantages reflected in its financial metrics [9]. - The company’s electric injection molding machines, particularly the Changfei series, are gaining traction globally, with over 30,000 units in use across approximately 60 countries [9].

Group 1 - The company reported a stable revenue growth of 12.5% year-on-year for the first half of 2025, reaching 9.02 billion RMB, with a gross margin of 32.8%, slightly up by 0.5 percentage points, primarily due to lower raw material prices [1] - The net profit attributable to shareholders was 1.71 billion RMB, reflecting a year-on-year increase of 12.6%, maintaining a stable net profit margin of 19% despite a high base effect [1] Group 2 - Sales volume increased across all models, with a total of 29,438 units sold in the first half of 2025, representing an 8.8% year-on-year growth, and an average selling price of 293,000 RMB, up by 2.8% [2] - The main models, Jupiter and Mars, generated revenues of 1.67 billion RMB and 5.85 billion RMB respectively, with year-on-year growth rates of 14.6% and 13.2% [2] - Domestic revenue remained flat at 5.2 billion RMB due to structural slowdown in domestic demand, while overseas sales surged by 34.7% to 3.82 billion RMB, increasing its revenue share to 42.3% [2] Group 3 - The company is accelerating overseas expansion to mitigate uncertainties, with new factories in Japan, Serbia, and India expected to commence operations in the second half of 2025, and a Malaysian factory projected to be fully operational by 2026 [2] - The company is expected to see significant revenue growth in overseas markets starting in 2026, benefiting from a balanced global layout that can effectively smooth out the impacts of supply chain restructuring [2] Group 4 - The target price for the company's stock is set at 30 HKD, with a buy rating, supported by its competitive position in the injection molding machine sector and advantages in overseas capacity, sales, and service support [2] - Revenue projections for 2025-2027 are estimated at 18 billion, 19 billion, and 20.4 billion RMB respectively, with net profits of 3.4 billion, 3.6 billion, and 4 billion RMB [2]

Core Viewpoint - Company achieved steady growth in H1 2025, driven by global supply chain restructuring and accelerated development in certain downstream industries [1][2] Financial Performance - Revenue for H1 2025 reached 9.02 billion RMB, a year-on-year increase of 12.5% [1] - Net profit attributable to shareholders was 1.71 billion RMB, up 12.6% year-on-year [1] - Earnings per share stood at 1.07 RMB [1] - Gross margin for H1 2025 was 32.8%, an increase of 0.5 percentage points year-on-year [1] - Net profit margin remained stable at 19.0% [1] - Operating cash inflow was 1.4 billion RMB, reflecting a growth of 16.3% [1] Downstream Market Recovery - Injection molding machine sales generated 8.64 billion RMB in revenue, a 12.1% increase year-on-year [1] - Components and services revenue reached 0.38 billion RMB, growing by 21.0% [1] - Demand from the automotive and home appliance sectors is expected to benefit from the new policy promoting equipment upgrades [1] Overseas Market Performance - Domestic revenue was 5.20 billion RMB, a slight increase of 0.3% [2] - Overseas revenue surged to 3.82 billion RMB, marking a 34.7% year-on-year growth [2] - The company’s "Five-Five" overseas strategy is enhancing global delivery capabilities [2] - New factories in Japan, Serbia, and Chennai, India, are set to commence operations in H2 2025 [2] Future Outlook - The company maintains profit forecasts for 2025-2027 at 3.50 billion, 3.90 billion, and 4.26 billion RMB, reflecting year-on-year growth of 13.5%, 11.6%, and 9.3% respectively [2] - Corresponding EPS forecasts are 2.19, 2.45, and 2.67 RMB [2] - The company expects continued performance improvement driven by equipment upgrades and overseas exports [2]

Group 1: Circle Internet Group (CRCL US) - Circle maintains a "Buy" rating with a target price adjusted to $212.0, down from $305.3[1] - Q2 2025 revenue increased by 53% year-on-year to $658 million, driven by USDC issuance growth[1] - Net loss for Q2 2025 was $482 million, primarily due to $591 million in IPO-related expenses, but adjusted EBITDA rose by 52% to $126 million[1] - Projected revenue growth rates for 2025-2027 are 60.3%, 76.7%, and 69.5% respectively, with net profit growth rates of 88.9%, 102.5%, and 102.7%[1] - The stablecoin market is expected to reach $320 billion, $600 billion, and $1 trillion in 2025, 2026, and 2027 respectively[1] Group 2: Industry Position and Risks - Circle's competitive advantages include regulatory compliance, ecosystem neutrality, and technological leadership in cross-chain interoperability[1] - Catalysts for growth include the expansion of the stablecoin market, regulatory acceptance, and the growth of real-world assets (RWA)[1] - Risks involve tightening regulations, increased competition, and lower-than-expected penetration rates in the stablecoin market[1] Group 3: Haitian International (01882 HK) - Haitian International upgraded to "Buy" with a target price raised to HKD 26.00, citing attractive valuation and strong future earnings growth expectations[5] - The company reported strong mid-term results with overseas sales growth exceeding expectations, while domestic sales remained stable[5] - Projected earnings per share for 2025-2027 are RMB 2.13 (+2.6%), RMB 2.03 (+1.4%), and RMB 2.30 (+1.7%) respectively[5] - Overseas sales reached RMB 3.818 billion, a year-on-year increase of 34.7%, with Southeast Asia showing particularly strong growth of 90.0%[5]

Company Research - Futu Holdings (FUTU) is rated "Buy" with a target price of $195.00, representing a potential upside of 15.71% from the current price of $168.52[3][14] - Haitong International (1882) is rated "Buy" with a target price of HKD 30.00, maintaining the same EPS estimates for 2025 and 2026[2][12] - China Resources Beer (291) is rated "Buy" with a target price of HKD 35.00, reflecting an 18x PE for 2025, with a projected EPS growth of 8% for 2026[2][28] Financial Performance - Futu Holdings expects total revenue to grow from HKD 10,008 million in 2023 to HKD 19,531 million in 2025, a growth rate of 43.7%[12] - The net profit for Futu Holdings is projected to increase from HKD 4,279 million in 2023 to HKD 9,413 million in 2025, representing a growth of 73.3%[12] - China Resources Beer reported a net profit of HKD 57.9 billion for the first half of 2025, a year-on-year increase of 23%[24] Market Trends - Futu Holdings is leveraging its technology and regulatory licenses to capture the cross-border wealth management market, with a focus on Southeast Asia and Web 3.0 innovations[10][8] - China Resources Beer is focusing on premiumization, with high-end product sales growing over 10%, significantly outperforming the industry[25][27] - Haitong International's overseas sales surged by 34.7% year-on-year, driven by demand in Southeast Asia and a strategic focus on key industry clients[20]

Core Viewpoint - CICC maintains the profit forecast for Haitian International (01882) at 3.64 billion and 4.067 billion yuan for 2025 and 2026 respectively, with the current stock price corresponding to 8.8x and 7.8x P/E for those years, indicating a 35% upside potential from the target price of 29.5 HKD, which corresponds to 11.8x and 10.5x P/E for 2025 and 2026 [1] Group 1: Revenue Performance - In 1H25, the company's revenue reached 9.018 billion yuan, representing a year-on-year growth of 12.5%, with net profit attributable to shareholders at 1.712 billion yuan, also up by 12.6% [1] - The growth in overseas markets was a significant contributor, with overseas revenue increasing by 34.7% year-on-year, while domestic sales grew by only 0.3% due to a high base and structural slowdown in domestic demand [2] - The sales of injection molding machines increased by 12.1% to 8.637 billion yuan, with parts and services sales rising by 21.0% to 381 million yuan [2] Group 2: Profitability and Efficiency - The company's gross margin in 1H25 was 32.8%, up by 0.5 percentage points year-on-year, primarily due to lower raw material prices, while the net profit margin remained stable at 19.0% [3] - Operating cash flow for 1H25 was 1.402 billion yuan, reflecting an increase of 197 million yuan year-on-year, indicating improved working capital management [3] Group 3: Global Expansion Strategy - The company is deepening its investment in overseas capacity and market development, with overseas revenue accounting for 42.3% of total revenue in 1H25, an increase of 6.9 percentage points year-on-year [4] - The company has been hosting open house events at its global factories, attracting over 3,000 clients, partners, and investors from more than 20 countries [4] - With the completion of the second phase of factories in Serbia and India expected in 2025, the company anticipates further increases in its overseas revenue share [4]

Core Viewpoint - CICC maintains the profit forecast for Haitian International (01882) at 3.64 billion and 4.067 billion yuan for 2025 and 2026 respectively, with the current stock price corresponding to a P/E of 8.8x and 7.8x for those years, indicating a 35% upside potential based on a target price of 29.5 HKD [1] Group 1: Financial Performance - In 1H25, the company's revenue reached 9.018 billion yuan, reflecting a year-on-year growth of 12.5%, while the net profit attributable to the parent company was 1.712 billion yuan, also up by 12.6% [1] - The company's 1H25 performance aligns with CICC's expectations, with overseas market demand being a significant contributor to growth, as overseas revenue increased by 34.7% [2] Group 2: Sales Breakdown - In 1H25, domestic and overseas sales were 5.20 billion and 3.82 billion yuan respectively, with domestic sales growing by 0.3% and overseas sales by 34.7% [2] - The growth in overseas sales is attributed to the company's ongoing international expansion and structural adjustments in the global supply chain, particularly in Southeast Asia [2] Group 3: Product Performance - Sales of injection molding machines increased by 12.1% to 8.637 billion yuan in 1H25, while parts and services sales rose by 21.0% to 381 million yuan [3] - The revenue from the Mars, Jupiter, and electric series in 1H25 was 5.855 billion, 1.672 billion, and 1.072 billion yuan respectively, with year-on-year growth rates of 13.2%, 14.7%, and 5.3% [3] Group 4: Profitability and Efficiency - The company's gross margin in 1H25 was 32.8%, an increase of 0.5 percentage points year-on-year, primarily due to lower raw material prices; the net profit margin remained stable at 19.0% [4] - The net cash flow from operating activities was 1.402 billion yuan, reflecting an increase of 197 million yuan year-on-year, indicating improved management of working capital [4] Group 5: Global Strategy - The company continues to deepen its overseas capacity investment and market expansion, with overseas revenue accounting for 42.3% of total revenue in 1H25, up by 6.9 percentage points year-on-year [5] - The company hosted open house events at its global factories, attracting over 3,000 clients, partners, and investors from more than 20 countries, indicating strong international engagement [5] - With the completion of the second phase of factories in Serbia and India expected in 2025, the company anticipates further increases in overseas revenue share [5]